Gynuity Health Projects

Reproductive & maternal health │Nonprofit with 20 plus years' experience generating & promoting evidence to guide policy & inspire innovative practice

[Gynuity Health Projects @Gynuity]

We're taking an indefinite break from Twitter/X. Find us on Bluesky and LinkedIn. Keep up to date with our work through our website https://t.co/1P8pH8mYrR

[carafem @carafem]

At carafem, we’ve seen firsthand how "missed period pills" can help people take control of their reproductive health through a study we participated in with @Gynuity, no confirmation of pregnancy required.

[Carrie N. Baker @CarrieNBaker]

A double dose of the emergency contraceptive ella along with #misoprostol is effective for early abortion, says new study from @Gynuity . @Plancpills https://t.co/A5OFyzFN6t

[Healio Women’s Health & OB/GYN @healiowomen]

📢 Data from a small study suggest ulipristal acetate plus #misoprotol was effective and safe for early #medicationabortion up to 63 days’ gestation, 💊 but more research is needed.

@NEJMEvidence @Gynuity
https://t.co/NLsG2qAY8n

[Gynuity Health Projects @Gynuity]

Estamos muy orgullosas(os) de presentar los resultados de un estudio colaborativo publicado en @NEJMEvidence que evalúa la posibilidad de #ulipristal en lugar de #mifepristona en un régimen combinado con #misoprostol para #abortoconmedicamentos --https://t.co/dcGI2n0P6z

[Gynuity Health Projects @Gynuity]

We're proud to present the results from a collaborative study assessing the possibility of #ulipristal instead of #mifepristone in a combined regimen with #misoprostol for #medicationabortion. @OPTinnovate. Article published in @NEJMEvidence -- https://t.co/dcGI2n0P6z

[Andrew Weeks @adweeks]

An insight into the birth preferences on women being induced in an Indian government hospital. Fascinating project to be involved with - thanks to Lydia Hawker and colleagues at @AIIMSNagpur @Gynuity @GMCNagpur @LightlyKate @kingdon_carol @LivUniMedicine @LivUni

[Gynuity Health Projects @Gynuity]

Induction of labor is an increasingly common intervention but experiences & preferences of induction methods are under-researched. Understanding these perspectives is important to improve the childbirth experience: https://t.co/DMojOePcSK in @AjogGlobal

[Gynuity Health Projects @Gynuity]

🧐https://t.co/RoYH14ALbT
➡️Published studies on #telemedicine medication #abortion & labor induction with oral #misoprostol for #hypertension in pregnancy
➡️Ongoing research on alternative abortifacients, ‘period pill’ regimens & a #postpartum self-care monitoring app

[Gynuity Health Projects @Gynuity]

Spoiler Alert. #Telemedicine medication abortion without in-person tests is safe, feasible and acceptable, according to our study in Ukraine, Uzbekistan, and Azerbaijan >> https://t.co/pUlYvaMlM3

[Gynuity Health Projects @Gynuity]

Today is #WorldPreeclampsiaDay. Check out the latest evidence on the use of low-dose oral #misoprostol tablets for labor induction in pregnancies complicated by #hypertension. Randomized trial results hot off the press➡️ https://t.co/eM7QcxUfDn

[SanyuResearch @ResearchSanyu]

Can you replace oxytocin infusion with oral misoprostol tablets when inducing labour? See the evidence from our multicentre randomised trial published today in BJOG. @NIHRresearch @The_MRC @LivUni @wellcometrust @WHO @Gynuity @LiverpoolWomens https://t.co/DUpSK0Sukn

[BMC Series @BMC_series]

A study published in #BMCMedResMethodol introduces PaGES: a Participant-Generated Experience and Satisfaction Index, a new Patient-Reported Outcomes or Experience Measures (PROMS/PREMS) evaluation tool. https://t.co/TciFXOtYYI

[Gynuity Health Projects @Gynuity]

Opportunities for philanthropic support of #abortion access and #reproductive rights. @BridgespanGroup Overview: https://t.co/ILJD8a62M3. Find @Gynuity alongside @avowtx @avowtexas @Guttmacher @nirhealth @SocietyFP under orgs that advance repro rights, justice and field building

[Gynuity Health Projects @Gynuity]

We're delighted to add Tanzania to our Map of #Mifepristone Approvals—https://t.co/lH7ObSWBib. We congratulate everyone involved in getting mifepristone approved, a decision that will help strengthen access to #reproductive healthcare options for individuals in Tanzania.

[Population Council @Pop_Council]

In a conversation w/ @themeteor, the Council's @lisabhaddad & @Gynuity's Beverly Winikoff discuss #mifepristone, the politics behind targeting the FDA’s approval of the abortion pill, & how the #SCOTUS decision may impact #reprohealth in the US.

Read: https://t.co/yEZslKjPsE

[Serra Sippel @SerraSippel]

👉🏽Beverly Winikoff @Gynuity: "no matter the outcome at the Supreme Court, medication abortion is here to stay" 💚via @andrew_chung_ @Reuters
https://t.co/nggqIrXVfv

[Gynuity Health Projects @Gynuity]

🧐https://t.co/z25yY8oeDt
👉Medication abortion screening by computer
👉Experiences & satisfaction with childbirth tool
👉Assessing misoprostol-only for #telemedicine #medicationabortion
👉Reproductive health #self-care in humanitarian & fragile settings
👉#SCOTUS amicus brief

[Gynuity Health Projects @Gynuity]

👏👏👏Senators in France overwhelmingly approve the inclusion in the Constitution of the "guaranteed freedom" of women "to have recourse to a voluntary termination of pregnancy", paving the way for final adoption of the text in Congress next month.

[Gynuity Health Projects @Gynuity]

We applaud Ecuador's Ministry of Health for successfully including mifepristone in its National Essential Medicines List, as well as those who helped make it happen.

Map available in Spanish https://t.co/IndS8uDDAh